TobiasBertsch_photo_new.jpg

Tobias Bertsch

Dr Tobias Bertsch, MD, PhD has been a senior consultant at the Foeldi Clinic in Hinterzarten, Germany since 2005, specializing in lymphology and bariatric medicine. He also serves as Secretary General of the German Society of Lymphology.

Dr. Bertsch is one of only two physicians in Germany who consults in an outpatient setting approved by the health insurance commission with patients who have lymphedema and lipedema. Dr. Bertsch and his team consult with approximately 4000 patients per year.

In 2012, Dr. Bertsch earned Specialist Certification of Obesity Professional Education (SCOPE), the only internationally-recognized certification in obesity management for health care professionals. 

He lectures extensively throughout Germany but also in other European countries, Canada and the United States. 


Kristiana_Gordon_photo.png

Kristiana Gordon

Dr Kristiana Gordon is a Consultant in Dermatology & Lymphovascular Medicine. She is Clinical Lead of the Lymphoedema Service at St George’s Hospital, London where her team cares for thousands of patients with lymphoedema and lipoedema from across the UK. She has completed specialist dermatology training and a doctorate in primary lymphoedema, and continues to pursue her research interests within the rapidly developing field of lymphovascular medicine and lipoedema


Jay_photo.jpg

Jay Granzow

Dr. Jay Granzow is an internationally respected lymphedema surgeon.  He serves as Professor of Surgery in the Division of Plastic Surgery at the UCLA David Geffen School of Medicine, and Assistant Chief of Plastic Surgery at Harbor-UCLA Medical Center.  He is Board Certified both in Plastic Surgery and Head and Neck Surgery. 

A pioneer in lymphedema surgery, Dr. Granzow successfully integrated lymphedema therapy with three types of lymphedema surgery including vascularized lymph node transfer (VLNT), lymphaticovenous anastomosis (LVA) and suction assisted protein lipectomy (SAPL).  He has published major scientific articles on lymphedema surgery in leading medical journals.  Dr. Granzow is a frequent lecturer at U.S. and international conferences, educating patients, therapists and physicians on the latest advances in lymphedema surgery as part of a holistic approach to lymphedema care.  Dr. Granzow provides lymphedema treatment for patients in his private medical practice located in the Los Angeles area.


Prof_Keith_Harding_photo.png

Keith Harding

Professor Keith Harding CBE FRCGP FRCP FRCS FLSW has had a longstanding interest in wound healing.  He has undergone training in both general surgery and general practice.  He was appointed as the first Director of the Wound Healing Research Unit in 1991.  From 2011 – 2013 he was Director of TIME Institute (Translation, Innovation, Methodology and Engagement) and Head of Wound Healing Research Unit, School of Medicine, Cardiff University and Clinical Lead for Wound Healing in the Cardiff & Vale NHS Trust.  In September 2013 he was appointed as Dean of Clinical Innovation at Cardiff University and in 2014 was appointed as Medical Director of the Welsh Wound Innovation Centre.  He is the Editor-in-Chief of the International Wound Journal published by Wiley ( IF 2.84).  He was the First President of the European Pressure Ulcer Advisory Panel, First Recorder of the European Wound Management Association and is a Past President of the European Tissue Repair Society.  He was Chair of the International Working Group on Wound Healing in Diabetic Foot Disease, Chair of the Expert Working Group that produced a range of International Consensus Documents from 2004 – 2017.  He was awarded the CBE in the New Year Honours list in January 2013 for Services to Medicine and Health Care.  In 2013 he was awarded £4.2 million to set up the Welsh Wound Innovation Initiative part of which has enabled the setting up of the first Wound Healing Centre in the World.  In 2014 he was awarded the The Learned Society of Wales Fellowship. In 2018 he is a Co Principal Investigator on a £24million European grant to establish a Clinical Innovation ecosystem across South Wales. He has also helped in the creation of a Welsh National respiratory disease innovation centre and £9million of funding has been secured to establish a series of Innovation Centres across Wales in other clinical areas. 


Judith_Photo.jpg

Judith Nudelman

Judith Nudelman, MD is a family medicine physician, a clinician and educator, a Clinical Associate Professor of Family Medicine at Brown University where she's taught for over 25 years. Her interest in Lymphedema started from personal experience and her clinical experience treating radiation oncology patients. She helped found a patient education website about lymphedema--stepupspeakout.org, she has served on the LANA board and has trained as a CLT. Her primary focus is on patient advocacy and lymphedema education both in medicine and for patients. 


Guillermo_photo.tif

Guillermo Oliver

Guillermo Oliver, Ph.D

Thomas D Spies Professor of Lymphatic Metabolism

Director Center for Vascular and Developmental Biology

Director, Regenerative Biology & Stem Cells Initiative 

Feinberg Cardiovascular and Renal Research Institute, Northwestern University

The Oliver Lab focuses on understanding how each specific cell type and organ acquires all its specific and unique morphological and functional characteristics during embryogenesis. Alterations in the cellular and molecular mechanisms controlling organ formation can result in major defects and pathological alterations. Almost 20 years ago, his laboratory identified the gene Prox1, a discovery that provided the first specific tools to dissect the process leading to the formation of the lymphatic vasculature. They generated the first animal models devoid of lymphatics and in a series of elegant studies they demonstrated that most embyonic lymphatics are venous derived and described the stepwise process leading to the formation of the lymphatic network. The tools and animals models his laboratory generated and generously distributed to laboratories around the world the field of lymphatic research in the last few years grew exponentially as we learned that lymphatics have a much more complex functional role than previously described in both, health and disease. For example, recently lymphatic mlarfunction have been associated to glaucoma, cardiac repair and Alzehimer’s disease. His laboratory also showed for the first time that a defective lymphatic vasculature can promote obesity and associated metabolic disorders. These fundamental discoveries impacted diverse fields including lymphedema, obesity, and cardiovascular research.


Stephanie_photo.jpg

Stephanie Ross

Dr. Stephanie Ross is a clinical health psychologist and founder of Illness Navigation Resources. She is also an assistant professor in the Department of Psychiatry and Behavioral Sciences at Northwestern University Feinberg School of Medicine. Dr. Ross earned her doctorate at Loyola University Chicago and completed a post-doctoral fellowship at Memorial Sloan-Kettering Cancer Center, where she served as chief research fellow in the Department of Psychiatry and Behavioral Sciences. She has extensive experience and expertise in working with oncology and other medical patients and their families. Dr. Ross is frequently asked to present to medical professionals and support groups about the emotional impact of cancer and other medical conditions. 


Taghian_picture_2016.jpg

Alphonse Taghian

Alphonse G. Taghian, MD, PHD, FASTRO 

Professor of Radiation Oncology, Harvard Medical School

Breast Radiation Oncology, Massachusetts General Hospital

Director, Lymphedema Research Program, 

Dr Alphonse Taghian, Professor of Radiation Oncology at Harvard Medical School, earned his Medical Degree from Alexandria University in Egypt. He completed his residency in Radiation Oncology in France, after which he pursued clinical and research fellowships at Gustave-Roussy Institut, Paris. 

After obtaining his PhD in Radiobiology from Paris XI University, Dr Taghian was appointed as staff in the Department of Radiation Oncology at Massachusetts General Hospital. He is now the Director of Lymphedema Research Program and Co-Director of the Breast Cancer Research Program at Massachusetts General Hospital. 

An internationally recognized leader in breast radiation oncology, in particular in the field of Accelerated Partial Breast Irradiation (APBI), Dr Taghian has published more than 180 peer reviewed articles, general reviews and chapters. He has edited 2 books, one of them on the multidisciplinary approach in the treatment of breast cancer.   He was awarded several NIH grants totaling around $2.7 Million for research in breast cancer related lymphedema. His main interests include screening and early intervention for lymphedema, methods to minimize cardiac exposure to radiation, accelerated partial breast irradiation and indications for post-mastectomy radiation.